Literature DB >> 23422869

Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study.

Melissa F Wellons1, Gordon Wright Bates, Pamela J Schreiner, David S Siscovick, Barbara Sternfeld, Cora E Lewis.   

Abstract

OBJECTIVE: The timing of menopause is associated with multiple chronic diseases. Tools that predict this milestone have relevance for clinical and research purposes. Among infertile women, a positive relationship exists between antral follicle count (AFC) and response to controlled ovarian hyperstimulation, a marker of ovarian reserve. However, an age-independent relationship between AFC and menopause has not been demonstrated. Thus, our objective was to evaluate the relationship between AFC measured in women aged 34 to 49 years and incident natural menopause during 7 years of follow-up.
METHODS: The Coronary Artery Risk Development in Young Adults Study is a longitudinal community-based study (Chicago, IL; Birmingham, AL; Minneapolis, MN; and Oakland, CA) begun in 1985-1986. In 2002-2003, the Coronary Artery Risk Development in Young Adults Women's Study measured follicle-stimulating hormone (FSH) levels and performed a transvaginal ultrasound protocol that included AFC (2-10 mm follicles on both ovaries). Incident natural menopause was assessed by surveys in 2005-2006 and 2009-2010.
RESULTS: In our sample (n = 456), the median (interquartile range) AFC and FSH level were 5 (2-9) and 7.8 (5.6-11.0) mIU/mL, respectively, at a mean (range) age of 42 (34-49) years in 2002-2003. One hundred one women reported natural menopause by 2009-2010. In Cox models, current smoking, stable menses, FSH level higher than 13 mIU/mL, and AFC of 4 or less were independently associated with incident natural menopause. Compared with AFC higher than 4, those with an AFC of 4 or less were nearly twice as likely to have undergone menopause during 7 years of follow-up (hazard ratio, 1.89; 95% CI, 1.19-3.02) after adjustment for covariates.
CONCLUSIONS: AFC has been found to be independently associated with natural menopause during 7 years of follow-up after controlling for other markers of ovarian aging.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422869      PMCID: PMC3675173          DOI: 10.1097/GME.0b013e31827f06c2

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  25 in total

1.  Executive summary: Stages of Reproductive Aging Workshop (STRAW).

Authors:  M R Soules; S Sherman; E Parrott; R Rebar; N Santoro; W Utian; N Woods
Journal:  Fertil Steril       Date:  2001-11       Impact factor: 7.329

2.  Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women.

Authors:  Bjarne K Jacobsen; Ivar Heuch; Gunnar Kvåle
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

3.  Cardiovascular risk factors in young adults. The CARDIA baseline monograph.

Authors:  G R Cutter; G L Burke; A R Dyer; G D Friedman; J E Hilner; G H Hughes; S B Hulley; D R Jacobs; K Liu; T A Manolio
Journal:  Control Clin Trials       Date:  1991-02

4.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Authors:  S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

5.  Clinical features of young women with hypergonadotropic amenorrhea.

Authors:  R W Rebar; H V Connolly
Journal:  Fertil Steril       Date:  1990-05       Impact factor: 7.329

6.  Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia.

Authors:  Erica T Wang; Ronit Calderon-Margalit; Marcelle I Cedars; Martha L Daviglus; Sharon S Merkin; Pamela J Schreiner; Barbara Sternfeld; Melissa Wellons; Stephen M Schwartz; Cora E Lewis; O Dale Williams; David S Siscovick; Kirsten Bibbins-Domingo
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

7.  Predicting age at menopause from serum antimüllerian hormone concentration.

Authors:  Fahimeh Ramezani Tehrani; Nezhat Shakeri; Masoud Solaymani-Dodaran; Fereidoun Azizi
Journal:  Menopause       Date:  2011-07       Impact factor: 2.953

8.  Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study.

Authors:  Edwina H Yeung; Cuilin Zhang; Sunni L Mumford; Aijun Ye; Maurizio Trevisan; Liwei Chen; Richard W Browne; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

9.  Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Climacteric       Date:  2012-02-16       Impact factor: 3.005

10.  CARDIA: study design, recruitment, and some characteristics of the examined subjects.

Authors:  G D Friedman; G R Cutter; R P Donahue; G H Hughes; S B Hulley; D R Jacobs; K Liu; P J Savage
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

View more
  8 in total

1.  Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.

Authors:  Catherine Kim; James C Slaughter; Erica T Wang; Duke Appiah; Pamela Schreiner; Benjamin Leader; Ronit Calderon-Margalit; Barbara Sternfeld; David Siscovick; Melissa Wellons
Journal:  Maturitas       Date:  2017-05-01       Impact factor: 4.342

2.  The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments.

Authors:  Irene Souter; Kristen W Smith; Irene Dimitriadis; Shelley Ehrlich; Paige L Williams; Antonia M Calafat; Russ Hauser
Journal:  Reprod Toxicol       Date:  2013-10-04       Impact factor: 3.143

3.  The association of protein intake (amount and type) with ovarian antral follicle counts among infertile women: results from the EARTH prospective study cohort.

Authors:  I Souter; Y-H Chiu; M Batsis; M C Afeiche; P L Williams; R Hauser; J E Chavarro
Journal:  BJOG       Date:  2017-04-10       Impact factor: 6.531

4.  Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.

Authors:  Sangeeta Nair; James C Slaughter; James G Terry; Duke Appiah; Imo Ebong; Erica Wang; David S Siscovick; Barbara Sternfeld; Pamela J Schreiner; Cora E Lewis; Edmond K Kabagambe; Melissa F Wellons
Journal:  Maturitas       Date:  2015-06-16       Impact factor: 5.110

5.  Antimüllerian hormone and F2-isoprostanes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Catherine Kim; James C Slaughter; James G Terry; David R Jacobs; Nisha Parikh; Duke Appiah; Benjamin Leader; Molly B Moravek; Melissa F Wellons
Journal:  Fertil Steril       Date:  2020-07-16       Impact factor: 7.490

Review 6.  The Bologna criteria for poor ovarian response: a contemporary critical appraisal.

Authors:  Johnny S Younis; Moshe Ben-Ami; Izhar Ben-Shlomo
Journal:  J Ovarian Res       Date:  2015-11-17       Impact factor: 4.234

7.  There is a Positive Correlation Between Socioeconomic Status and Ovarian Reserve in Women of Reproductive Age.

Authors:  Mert Ulas Barut; Elif Agacayak; Murat Bozkurt; Tarık Aksu; Talip Gul
Journal:  Med Sci Monit       Date:  2016-11-16

8.  Study protocol for a randomised controlled trial on the use of intraoperative ultrasound-guided laparoscopic ovarian cystectomy (UGLOC) as a method of fertility preservation in the management of benign ovarian cysts.

Authors:  Lorraine S Kasaven; Benjamin P Jones; Sadaf Ghaem-Maghami; Jan Yvan Jos Verbakel; Mona El-Bahrawy; Srdjan Saso; Joseph Yazbek
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.